AgeX Therapeutics, Inc.

AMEX:AGE

0.4 (USD) • At close November 27, 2023
Bedrijfsnaam AgeX Therapeutics, Inc.
Symbool AGE
Munteenheid USD
Prijs 0.43
Beurswaarde 16,326,649
Dividendpercentage 0%
52-weken bereik 0.361 - 1
Industrie Biotechnology
Sector Healthcare
CEO Dr. Joanne M. Hackett Ph.D.
Website https://www.agexinc.com

An error occurred while fetching data.

Over AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as

Vergelijkbare Aandelen

BiomX Inc. logo

BiomX Inc.

PHGE

0.41 USD

NanoViricides, Inc. logo

NanoViricides, Inc.

NNVC

1.1 USD

Timber Pharmaceuticals, Inc. logo

Timber Pharmaceuticals, Inc.

TMBR

1.461 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)